Inhalation of estradiol for sustained systemic delivery

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 12, Issue 1, 1999, Pages 27-36

  Wang, Jue ^a   Ben Jebria, Abdelaziz ^a   Edwards, David A ^a,b,c  

^a The Pennsylvania State University   (United States)

^b Advanced Inhalation Research   (United States)

^c Advanced Inhalation Research Inc   (United States)

Author keywords

DPI; Dry powders; Estradiol; Porous; Sustained release

Indexed keywords

ESTRADIOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; INHALATIONAL DRUG ADMINISTRATION; LUNG LAVAGE; MALE; NONHUMAN; POWDER; RAT; SUSTAINED RELEASE FORMULATION;

EID: 0033051713     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1999.12.27     Document Type: Article

References (23)

1. Service, R.F. 1997. Drug delivery takes a deep breath. Science. 277:1199-1201.
2. Dupont, W.D., and D.L. Page. 1991. Menopausal estrogen replacement therapy and breast cancer. Arch. Intern. Med. 151:67-72.
3. Service, R.F. 1998. New role for estradiol in cancer? Science. 279:1631-1633.
4. Nachtigall, L.E., and J.R. Heilman. 1991. Estrogen. Harper Perennial, New York.
5. Flynn, G.L. 1989. Mechanisms-methodology-drug delivery. In R. Guy, ed., Percutaneous Absorption. Marcel Dekker, New York, 27-51.
6. Klein, R., and L. Berlin. 1997. Benefits and risks of hormone replacement therapy. In E.J. Pavlik, ed. Estrogens, Progestins, and Their Antagonist, vol 1. Birkhauser, New York, 16-40.
7. Patton, J. 1996. Mechanisms of macromolecule absorption by the lung. Adv. Drug Deliv. Rev. 19:3-36.
8. Timsina, M.P., G.P. Martin, C. Marriott, D. Ganderton, and M. Yianneskis. 1994. Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 101:1-13.
9. Gonda, I. 1992. Targeting by deposition. In A.J. Hickey, ed. Pharmaceutical Inhalation Aerosol Technology. Marcel Dekker, New York, 62-95.
10. Zeng, X.M., G.P. Martin, and C. Marriott. 1995. The controlled delivery of drugs to the lung. Int. J. Pharm. 124:149-164.
11. Edwards, D.A., J. Hanes, G. Caponetti, J. Hrkach, N. Lotan, A. Ben-Jebria, and R. Langer. 1997. Large porous particles for pulmonary drug delivery. Science. 276:1868-1871.
12. Vanbever, R., J. Mintzes, J. Wang, J. Nice, D. Chen, R. Langer, and D.A. Edwards. 1998. Formulation and physical characterization of large porous particles for inhalation. J. Pharm. Res. (in press).
13. Phillips, M.C., and H. Hauser. 1974. Lung surfactant properties. J. Colloid Interface Sci. 49:31-39.
14. Bangham, A.D., C.J. Morley, and M.C. Phillips. 1979. The physical properties of an effective lung surfactant. Biochim. Biophys. Acta. 573:552-556.
15. Kabasakalian, P., E. Britt, and M.D. Yudis. 1966. Solubility of some steroids in water. J. Pharm. Sci. 55: 642-650.
16. Clark, A.R., and M. Egan. 1994. Modeling the deposition of inhaled powdered drug aerosols. J. Aerosol Sci. 25:175-186.
17. Patton, J.S., and R.M. Platz. 1992. Inhalation of proteins for systemic administration. Adv. Drug Deliv. Rev. 8:179-186.
18. Heyder, J., J. Gebhard, G. Hiegwer, C. Broth, and W. Stahlhofen. 1973. Experimental studies of the total deposition of aerosol particles in the human respiratory tract. J. Aerosol Sci. 4:191-208.
19. Nichols, W.K. 1995. Hormones. In Gennaro, A.R., ed. Remington: The Science and Practice of Pharmacy, vol 1., ed 19. Mack Publishing Co, Easton, PA, 1057-1105.
20. Batycky, R.P., J. Hanes, R. Langer, and D.A. Edwards. 1997. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J. Pharm. Sci. 86:1464-1477.
21. Tabata, Y., and Y. Ikada. 1988. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials. 9:356-362.
22. Schreier, H., K.J. McNichol, M. Ausborn, D.M. Soucy, H. Derendorf, A.A. Stecenko, and R.J. Gonzalez-Rothi. 1992. Pulmonary delivery of amikacin liposomes and acute liposome toxicity in the sheep. Int. J. Pharm. 87:183-193.
23. Liu, F.Y., Z. Shao, D.O. Kildsig, and A.K. Mitra. 1993. Pulmonary delivery of free and liposomal insulin. Pharm. Res. 10:228-232.